KALA - Kala Pharmaceuticals Inc. (KALA) CEO Mark Iwicki on Q2 2021 Results - Earnings Call Transcript

Kala Pharmaceuticals, Inc. (KALA) Q2 2021 Earnings Conference Call August 5, 2021 8:00 AM ET Company Participants Niranjan Kameswaran - Senior Vice President of Strategy Mark Iwicki - Chairman, President & Chief Executive Officer Todd Bazemore - Chief Operating Officer Mary Reumuth - Chief Financial Officer Kim Brazzell - Chief Medical Officer Conference Call Participants Chris Neyor - JPMorgan François Brisebois - Oppenheimer Tazeen Ahmad - Bank of America Chris Howerton - Jefferies Yi Chen - H.C. Wainwright Tim Chiang - Northland Capital Presentation Operator Good morning, and welcome to Kala Pharmaceuticals' Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following managements prepared remarks, a Q&A session will be held. As a reminder, this call is being recorded. I would now like to turn the conference over to Niranjan Kameswaran, Senior Vice President of Strategy for Kala Pharmaceuticals. Please proceed. Niranjan

For further details see:

Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q2 2021 Results - Earnings Call Transcript